Mark Goldberg
SlowingNamed in filings at Chemistry VenturesOn the current fund
- Board seats filed
- 7
Named in filings at Chemistry VenturesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| INTENSITY THERAPEUTICS | Biotech & pharma | November 2024 | None on file |
| Motive Technologies | Logistics & supply chain | April 2021 | Institutional Venture Partners, Kleiner Perkins, Scale Venture Partners |
| Biofeedback Design | Digital health | October 2020 | None on file |
| Pilot.com | Fintech | July 2020 | Kleiner Perkins |
| Built Technologies | Fintech | October 2017 | Addition Five, Addition Four, Addition One, Addition Six, Addition Three, Addition Two, Tiger Global |
| aTYR PHARMA | Biotech & pharma | August 2017 | Domain Partners, Polaris Partners |
| Metropolitan Bank Holding | Not yet classified | April 2015 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Mark Goldberg on the board, based on 6 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.